American pharmaceutical company
Catch the Replay for Splash with MASH! Top experts share which patients are most at risk, how to risk-stratify patients, and review candidates for new or ... Show more
A Splash With MASH
A Splash With MASH
Corcept Therapeutics: Key Catalysts Ahead: Corcept reported strong Q4 results but also faces litigation challenges. 2024 is likely to be an inflection year on ...
seekingalpha.com/article/4671385-corcept-therapeutics-key-catalysts-ahead
Paid articlePaid
Corcept Therapeutics Stock Is Down 27%. It’s an ‘Ideal Buying Opportunity.’: Shares of the drugmaker Corcept Therapeutics were on track for their worst day in ...
barrons.com/articles/corcept-therapeutics-stock-teva-ruling-buy-4a1d6380
Paid articlePaid Nonalcoholic Steatohepatitis: Mission Possible!: Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic ...
medscape.org/viewarticle/998939
Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit
medscape.org/viewarticle/998763
Corcept loses patent spat against Teva, shares tumble
reuters.com/legal/us-judge-rules-against-corcept-patent-infringement-spat-with-teva-2023-12-29/
Nonalcoholic Steatohepatitis: Mission Possible!: Learn to recognize, diagnose, and manage nonalcoholic steatohepatitis (NASH) and metabolic ...
medscape.org/viewarticle/998939
❓ Treatment decisions can be challenging for steatotic liver disease. How do you compare with the experts? ms.spr.ly/6189ib0uz
Wall Street Breakfast Podcast: Fewer EV Models Qualify For Full Tax Credit: 2024 electric vehicle jolt - fewer models qualify for the full tax credit ...
seekingalpha.com/article/4660735-wall-street-breakfast-podcast-fewer-ev-models-qualify-for-full-tax-credit
Why Corcept's Not-Abortion Pill — And Stock — Is Getting Renewed Attention: Biotech stock Corcept is flirting with a buy point after the U.S ...
investors.com/news/technology/biotech-stock-why-corcept-not-abortion-pill-is-getting-renewed-attention/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics